Skip to main navigation
Logo - Color
Top Bar Links
Who We Are
Who We Are
Leadership
Our Culture
Careers
Contact Us
Contact Us
General Inquiries
Clinical Trial Information
Medical Information Request
Search
Our Science
Our Science
Pipeline
RAS Pathway
Avutometinib (RAF/MEK Clamp)
Defactinib (FAK Inhibitor)
Avutometinib as a Backbone of Therapy
Clinical Trials
Resources
Our Medicines
Medical Professionals
Overview
HCP Resources
Request Medical Information
Medical Education Grants and Scholarships
Investigator Sponsored Trials
Expanded Access
Patients & Advocacy
Investors & Media
Investor Relations
Overview
News & Media
Press Releases
Media Resources
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
IR Resources
Top Bar Links
Who We Are
Who We Are
Leadership
Our Culture
Careers
Contact Us
Contact Us
General Inquiries
Clinical Trial Information
Medical Information Request
<<
Back
Michael Schmidt, Ph.D.
Guggenheim Securities, LLC
